3-Aryl/Heteroary1-5-amino-1-(3′,4′,5′-trimethoxybenzoy1)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization

被引:17
作者
Romagnoli, Romeo [1 ]
Prencipe, Filippo [1 ]
Oliva, Paola [1 ]
Baraldi, Stefania [1 ]
Baraldi, Pier Giovanni [1 ]
Brancale, Andrea [2 ]
Ferla, Salvatore [2 ]
Hamel, Ernest [3 ]
Bortolozzi, Roberta [4 ]
Viola, Giampietro
机构
[1] Univ Ferrara, Dipartimento Sci Chim & Farmaceut, I-44121 Ferrara, Italy
[2] Cardiff Univ, Sch Pharm & Pharmaceut Sci, King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales
[3] NCI, Screening Technol Branch, Dev Therapeut Program,NIH, Div Canc Treatment & Diag,Frederick Natl Lab Canc, Frederick, MD 21702 USA
[4] Univ Padua, Lab Oncoematol, Dipartimento Salute Donna & Bambino, I-35131 Padua, Italy
关键词
Microtubule targeting-agent; Structure-activity relationship; Tubulin polymerization; Antiproliferative activity; Molecular docking; COLCHICINE BINDING-SITE; MICROTUBULE ORGANIZATION; ANTICANCER AGENTS; SOLID TUMORS; CANCER; GROWTH; 3(5)-AMINO-1,2,4-TRIAZOLES; COMBRETASTATIN-A-4; DERIVATIVES; ANALOGS;
D O I
10.1016/j.bioorg.2018.06.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many natural and synthetic substances are known to interfere with the dynamic assembly of tubulin, preventing the formation of microtubules. In our search for potent and selective antitumor agents, a novel series of 1(3',4',5'-trimethoxybenzoyl)-5-amino-1,2,4-triazoles were synthesized. The compounds had different heterocycles, including thiophene, furan or the three isomeric pyridines, and they possessed a phenyl ring bearing electron-releasing or electron-withdrawing substituents at the 3-position of the 5-amino-1,2,4-triazole system. Most of the twenty-two tested compounds showed moderate to potent antiproliferative activities against a panel of solid tumor and leukemic cell lines, with four (5j, 5k, 5o and 5p) showing strong antiproliferative activity (IC50 < 1 mu M) against selected cancer cells. Among them, several molecules preferentially inhibited the proliferation of leukemic cell lines, showing IC50 values 2-100-fold lower for Jurkat and RS4;11 cells than those for the three lines derived from solid tumors (HeLa, HT-29 and MCF-7 cells). Compound 5k strongly inhibited tubulin assembly, with an IC50 value of 0.66 mu M, half that obtained in simultaneous experiments with CA-4 (IC50 = 1.3 mu M).
引用
收藏
页码:361 / 374
页数:14
相关论文
共 45 条
  • [31] Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors
    Nishio, Makoto
    Satouchi, Miyako
    Horiike, Atsushi
    Horio, Yoshitsugu
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Hida, Toyoaki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (04) : 322 - 328
  • [32] Microtubule Targeting Agents: A Benchmark in Cancer Therapy
    Nitika, Verma
    Kapil, Khatri
    [J]. CURRENT DRUG THERAPY, 2013, 8 (03) : 189 - 196
  • [33] Novel combretastatin analogues effective against murine solid tumors: Design and structure-activity relationships
    Ohsumi, K
    Nakagawa, R
    Fukuda, Y
    Hatanaka, T
    Morinaga, Y
    Nihei, Y
    Ohishi, K
    Suga, Y
    Akiyama, Y
    Tsuji, T
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (16) : 3022 - 3032
  • [34] Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents
    Patil, Pravin O.
    Patil, Ashwini G.
    Rane, Rajesh A.
    Patil, Pravin C.
    Deshmukh, Prashant K.
    Bari, Sanjay B.
    Patil, Dilip A.
    Naphade, Shital S.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 955 - 969
  • [35] ANTINEOPLASTIC AGENTS .145. ISOLATION AND STRUCTURE OF THE STRONG CELL-GROWTH AND TUBULIN INHIBITOR COMBRETASTATIN-A-4
    PETTIT, GR
    SINGH, SB
    HAMEL, E
    LIN, CM
    ALBERTS, DS
    GARCIAKENDALL, D
    [J]. EXPERIENTIA, 1989, 45 (02): : 209 - 211
  • [36] The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization
    Prota, Andrea E.
    Danel, Franck
    Bachmann, Felix
    Bargsten, Katja
    Buey, Ruben M.
    Pohlmann, Jens
    Reinelt, Stefan
    Lane, Heidi
    Steinmetz, Michel O.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (08) : 1848 - 1860
  • [37] Microtubule dynamics as a target in oncology
    Risinger, April L.
    Giles, Francis J.
    Mooberry, Susan L.
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (03) : 255 - 261
  • [38] Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities
    Rohena, Cristina C.
    Mooberry, Susan L.
    [J]. NATURAL PRODUCT REPORTS, 2014, 31 (03) : 335 - 355
  • [39] Synthesis, Antimitotic and Antivascular Activity of 1-(3′,4′,5′-Trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Salvador, Maria Kimatrai
    Prencipe, Filippo
    Bertolasi, Valerio
    Cancellieri, Michela
    Brancale, Andrea
    Hamel, Ernest
    Castagliuolo, Ignazio
    Consolaro, Francesca
    Porcu, Elena
    Basso, Giuseppe
    Viola, Giampietro
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6795 - 6808
  • [40] Synthesis and Biological Evaluation of 2-(Alkoxycarbonyl)-3-Anilinobenzo[b]thiophenes and Thieno[2,3-b]pyridines as New Potent Anticancer Agents
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Salvador, Maria Kimatrai
    Preti, Delia
    Tabrizi, Mojgan Aghazadeh
    Bassetto, Marcella
    Brancale, Andrea
    Hamel, Ernest
    Castagliuolo, Ignazio
    Bortolozzi, Roberta
    Basso, Giuseppe
    Viola, Giampietro
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) : 2606 - 2618